Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' FABRE N' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 45 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fabre, N; Rustan, I; de Hoffmann, E; Quetin-Leclercq, J
      Determination of flavone, flavonol, and flavanone aglycones by negative ion liquid chromatography electrospray ion trap mass spectrometry

      JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
    2. Rascol, O; Arnulf, I; Paul, HPS; Brefel-Courbon, C; Vidailhet, M; Thalamas, C; Bonnet, AM; Descombes, S; Bejjani, B; Fabre, N; Montastruc, JL; Agid, Y
      Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease

      MOVEMENT DISORDERS
    3. Rascol, O; Fabre, N
      Dyskinesia: L-dopa-induced and tardive dyskinesia

      CLINICAL NEUROPHARMACOLOGY
    4. Frechard, A; Fabre, N; Pean, C; Montaut, S; Fauvel, MT; Rollin, P; Fouraste, I
      Novel indole-type glucosinolates from woad (Isatis tinctoria L.)

      TETRAHEDRON LETTERS
    5. Chaynes, P; Bousquet, P; Fabre, N; Lazorthes, Y
      Transient hemiballismus secondary to minimal head trauma

      REVUE NEUROLOGIQUE
    6. Vigor, C; Fabre, N; Fouraste, I; Moulis, C
      Three clerodane diterpenoids from Croton eluteria Bennett

      PHYTOCHEMISTRY
    7. Rascol, O; Nutt, JG; Blin, O; Goetz, CG; Trugman, JM; Soubrouillard, C; Carter, JH; Currie, LJ; Fabre, N; Thalamas, C; Giardina, WJ; Wright, S
      Induction by dopamine D-1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease

      ARCHIVES OF NEUROLOGY
    8. Schon, JH; Arushanov, E; Fabre, N; Bucher, E
      Transport properties of n-type CuGaSe2

      SOLAR ENERGY MATERIALS AND SOLAR CELLS
    9. Fabre, N
      Treatment of cluster headache.

      REVUE NEUROLOGIQUE
    10. Sabatini, U; Boulanouar, K; Fabre, N; Martin, F; Carel, C; Colonnese, C; Bozzao, L; Berry, I; Montastruc, JL; Chollet, F; Rascol, O
      Cortical motor reorganization in akinetic patients with Parkinson's disease - A functional MRI study

      BRAIN
    11. Conedera, V; Le Goff, B; Fabre, N
      Potentialities of a new positive photoresist for the realization of thick moulds

      JOURNAL OF MICROMECHANICS AND MICROENGINEERING
    12. Agid, Y; Destee, A; Durif, F; Montastruc, JL; Pedarriosse, AM; Deptula, D; Hoffman-La Roche, F; Pollak, P; Bonnet, AM; Allain, H; le Cavorzin, P; Barroche, G; Blin, O; Cesaro, P; Chazot, G; Broussolle, E; Leduc, V; Debilly, B; Feve, JR; Geraud, G; Fabre, N; Gu, C; Gil, R; Henry, P; Tison, F; Ansquer, O; Brefel, C; Payen, I; Said, G; Plante, V; Touchon, J; Cesari, JB; Camu, W; Bennys, K; Viallet, F; Warter, JM; Tranchant, C; Ziegler, M
      Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated parkinsonian patients

      MOVEMENT DISORDERS
    13. Aubertin, A; Fabre-Thorpe, M; Fabre, N; Geraud, G
      Migraine and speed of processing in fast visual categorisation

      COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES
    14. Rascol, O; Blin, O; Thalamas, C; Descombes, S; Soubrouillard, C; Azulay, P; Fabre, N; Viallet, F; Lafnitzegger, K; Wright, S; Carter, JH; Nutt, JG
      ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease

      ANNALS OF NEUROLOGY
    15. Gomez-Brouchet, A; Cintas, P; Lagier, E; Voisin, T; Delisie, MB; Fabre, N; Gerand, G; Salvayre, R; Levade, T
      Adult Sandhoff disease presenting with chronic diarrhoea

      JOURNAL OF INHERITED METABOLIC DISEASE
    16. Jacquemond-Collet, I; Hannedouche, S; Fabre, N; Fouraste, I; Moulis, C
      Two tetrahydroquinoline alkaloids from Galipea officinalis

      PHYTOCHEMISTRY
    17. Hannedouche, S; Jacquemond-Collet, I; Fabre, N; Stanislas, E; Moulis, C
      Iridoid keto-glycosides from Caryopteris x Clandonensis

      PHYTOCHEMISTRY
    18. Fabre-Jonca, N; Viard, I; French, LE; Masson, D
      Upregulation and redistribution of E-MAP-115 (epithelial microtubule-associated protein of 115 kDa) in terminally differentiating keratinocytes is coincident with the formation of intercellular contacts

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    19. Schon, JH; Oestreich, J; Schenker, O; Riazi-Nejad, H; Klenk, M; Fabre, N; Arushanov, E; Bucher, E
      n-type conduction in Ge-doped CuGaSe2

      APPLIED PHYSICS LETTERS
    20. FABRE N; BREFEL C; SABATINI U; CELSIS P; MONTASTRUC JL; CHOLLET F; RASCOL O
      NORMAL FRONTAL PERFUSION IN PATIENTS WITH FROZEN GAIT

      Movement disorders
    21. Rakotoson, JH; Fabre, N; Jacquemond-Collet, I; Hannedouche, S; Fouraste, I; Moulis, C
      Alkaloids from Galipea officinalis

      PLANTA MEDICA
    22. PASQUIER S; MENY C; ASADAUSKAS L; LEOTIN J; ARONZON BA; RYLKOV VV; CONEDERA V; FABRE N; REGOLINI JL; MORIN C
      PHOTOFIELD INTERFACE IMPURITY SPECTROSCOPY IN BLOCKED IMPURITY BAND SI-B STRUCTURES

      Journal of applied physics
    23. ADELMAN JU; BAUMEL B; CADY RK; BAKER CC; COUCH JR; DALESSIO DJ; DIAMOND S; ELKIND AH; FOSTER CA; GOLDSTEIN J; KATZ DA; KIRCHNER JR; KLAPPER JA; KUDROW DB; KUNKEL R; LANDY SH; LICHT JM; LINDER SL; LODER E; MARKLEY HG; MATHEW NT; MEYER JS; NETT R; PACKARD RC; PERSE T; PETERS KS; RAMADAN NM; RAPOPORT AM; ROSING HS; SADOWSKY C; SAPER JR; SHARFMAN MI; SILBERSTEIN SD; SINGER RP; SMITH R; SOLOMON G; SOLOMON S; STARK SR; SWANSON JW; TAYLOR FR; TEPPER SJ; TUCHMAN MM; VIJAYAN N; WALKER J; WARD T; WARNER JS; WENDT JK; WINNER P; BERAN P; BLACK A; DONNAN G; HERKES G; LORD G; ZAGAMI A; BAUMHACKL U; BROUSSALIS T; KLINGLER D; LADURNER G; JACQUY J; LOUIS P; SCHOENEN J; GAWEL MJ; HANSEN PE; JENSEN K; PEDERSEN KK; KORSGAARD A; LADEMANN A; OLESEN J; SIMONSEN N; SORENSEN PS; JENSEN TS; TFELTHANSEN P; KAASIK AE; ZUPPING R; FARKKILA M; HAANPAA M; HAVANKA H; HEDMAN C; ILMAVIRTA M; KINNUNEN E; LIUKKONEN J; PARTINEN M; RAUTAKORPI I; REUNANEN M; SAKO E; SEPPA JM; BAREGE M; CHAZOT G; COLOMBANI JP; DUJARDIN M; FABRE N; GIACOMINO A; GERAUD G; HENRY P; JOGEIX; LAPORTE A; LICHTBLAU; MASSIOU H; MAZINGUEDESAILLY; MIHOUT B; PETIT H; VEYRIE M; VILAREM H; WILMANN JF; BECKMANNREINHOLDT A; DIENER HC; EVERS S; GOBEL H; KLEPEL H; KUHL W; LANGOHR HD; NEU I; PAULUS W; PEIKERT A; PFAFFENRATH V; SCHOLZ E; STRAUBE A; WITTE OW; HARMOUSI S; KARAGEORGIOU C; MILONAS I; GIACOVAZZO M; NAPPI G; TERBERG JWM; SANDERS EACM; VANDERZWAN JL; EDLAND A; ENGELSEN B; GRONNING M; HALDORSEN T; HODNEBO A; LARSEN JP; DORNZAL T; PRUSINSKI A; SZCZUDLIK A; NAYA MG; GRANELL AN; LAINEZ JM; LEIRA R; LIANO H; PASCUAL J; BOIVIE J; DAHLOF C; EDVINSSON L; HARDEBO JE; NILSSON H; WALDENLIND E; ISLER HR; CRAWFORD P; DOWSON AJ; FINDLEY L; GROSS M; HAWKES CH; JESTICO J; ROLAN P; STEINER TJ; WILKINSON M; WAGNER G
      THE LONG-TERM TOLERABILITY AND EFFICACY OF ORAL ZOLMITRIPTAN (ZOMIG, 311C90) IN THE ACUTE TREATMENT OF MIGRAINE - AN INTERNATIONAL STUDY

      Headache
    24. RASCOL O; SABATINI U; BREFEL C; FABRE N; RAI S; SENARD M; CELSIS P; VIALLARD G; MONTASTRUC JL; CHOLLET F
      CORTICAL MOTOR OVERACTIVATION IN PARKINSONIAN-PATIENTS WITH L-DOPA-INDUCED PEAK-DOSE DYSKINESIA

      Brain
    25. CONEDERA V; FABRE N; DILHAN M
      A SIMPLE OPTICAL-SYSTEM TO OPTIMIZE A HIGH DEPTH TO WIDTH ASPECT RATIO APPLIED TO A POSITIVE PHOTORESIST LITHOGRAPHY PROCESS

      Journal of micromechanics and microengineering
    26. FABRE N; BON M; MOULIS C; FOURASTE I; STANISLAS E
      3 GLUCOSINOLATES FROM SEEDS OF BRASSICA-JUNCEA

      Phytochemistry
    27. RASCOL O; BLIN O; DESCOMBES S; SOUBROUILLIARD C; FABRE N; VIALLET F; THALAMAS C; AZULAY JP; LAFNITZEGGER K; FREDRICK E; WRIGHT S; NUTT J
      ABT-431, A SELECTIVE D1 AGONIST HAS EFFICACY IN PATIENTS WITH PARKINSONS-DISEASE

      Neurology
    28. SIEGFRIED J; BLOND S; BENABID A; DESTEE A; FRANCKE JP; KERAVEL Y; NGUYEN JP; PARENT A; RASCOL O; CASSIM F; CICCHETTI F; DEFEBVRE L; FABRE N; MARTINAT P; PRUVO JP; SABATINI U; SIGAL R; TAUB E; KELLY PJ
      SOCIETE-DE-NEUROCHIRURGIE-DE-LANGUE-FRANC AISE, 47TH ANNUAL-MEETING, MARRAKECH, 25-28 1997 - NEUROSURGICAL TREATMENT OF PARKINSONS-DISEASE AND OTHER MOVEMENT-DISORDERS

      Neuro-chirurgie
    29. RASCOL O; SABATINI U; FABRE N; BREFEL C; LOUBINOUX I; CELSIS P; SENARD JM; MONTASTRUC JL; CHOLLET F
      THE IPSILATERAL CEREBELLAR HEMISPHERE IS OVERACTIVE DURING HAND MOVEMENTS IN AKINETIC PARKINSONIAN-PATIENTS

      Brain
    30. FABRE N; FAUCHEUX JM; ROLAND Y; CANTAGREL A; GERAUD G
      CORTICOSTEROID-RESPONSIVE PARKINSONISM ASSOCIATED WITH PRIMARY SJOGRENS-SYNDROME - REPORT OF 2 CASES

      Neurology
    31. ROUSSET V; JOACHIM C; ITOUA S; ROUSSET B; FABRE N
      FABRICATION OF BURIED COPLANAR METAL-INSULATOR-METAL NANOJUNCTIONS WITH A GAP LOWER THAN 10 NM

      Journal de physique. III
    32. CONEDERA V; FABRE N; CAMON H; ROUSSET B; PHAM HH; SOLANO C
      FIRST STEPS TOWARDS THE FABRICATION OF ELECTROSTATIC MICROMOTORS USING SOG

      Sensors and actuators. A, Physical
    33. MONTASTRUC JL; FABRE N; BLIN O; SENARD JM; RASCOL O; RASCOL A
      DOES FLUOXETINE AGGRAVATE PARKINSONS-DISEASE - A PILOT PROSPECTIVE-STUDY

      Movement disorders
    34. RASCOL O; SABATINI U; FABRE N; SENARD JM; SIMONETTAMOREAU M; MONTASTRUC JL; CLANET M; RASCOL A
      ABNORMAL VESTIBULOOCULAR REFLEX CANCELLATION IN MULTIPLE SYSTEM ATROPHY AND PROGRESSIVE SUPRANUCLEAR PALSY BUT NOT IN PARKINSONS-DISEASE

      Movement disorders
    35. ITOUA S; JOACHIM C; ROUSSET B; FABRE N
      FABRICATION OF 30 NM INTER-ELECTRODE GAP COPLANAR TUNNEL-JUNCTIONS WITH BURIED ELECTRODES

      Journal de physique. III
    36. RASCOL O; FABRE N; BLIN O; POULIK J; SABATINI U; SENARD JM; ANE M; MONTASTRUC JL; RASCOL A
      NALTREXONE, AN OPIATE ANTAGONIST, FAILS TO MODIFY MOTOR SYMPTOMS IN PATIENTS WITH PARKINSONS-DISEASE

      Movement disorders
    37. MONTASTRUC JL; FABRE N; RASCOL O; SENARD JM; BLIN O
      N-METHYL-D-ASPARTATE (NMDA) ANTAGONIST AND PARKINSONS-DISEASE - A PILOT-STUDY WITH DEXTROMETHORPHAN

      Movement disorders
    38. KARRAY H; HENRY S; ICART J; FABRE N; VAYR R; DIDIER J
      2 CASES OF EPSTEIN-BARR PRIMARY INFECTION INITIATED BY MENINGOENCEPHALITIS

      Medecine et maladies infectieuses
    39. PASCALI P; SORBETTE F; SENARD JM; FABRE N; RASCOL O; MONTASTRUC JL
      SIDE-EFFECTS OF HYDROXYZINE

      Therapie
    40. RASCOL O; SABATINI U; CHOLLET F; FABRE N; SENARD JM; MONTASTRUC JL; CELSIS P; MARCVERGNES JP; RASCOL A
      NORMAL ACTIVATION OF THE SUPPLEMENTARY MOTOR AREA IN PATIENTS WITH PARKINSONS-DISEASE UNDERGOING LONG-TERM TREATMENT WITH LEVODOPA

      Journal of Neurology, Neurosurgery and Psychiatry
    41. SPECTOR NL; MEHLEN P; RYAN C; HARDY L; SAMSON W; LEVINE H; NADLER LM; FABRE N; ARRIGO AP
      REGULATION OF THE 28 KDA HEAT-SHOCK PROTEIN BY RETINOIC ACID DURING DIFFERENTIATION OF HUMAN LEUKEMIC HL-60 CELLS

      FEBS letters
    42. FABRE N
      BROTHERS AND SISTERS -TALES - SEXUAL IDENTITY AND DREAMS OF BISEXUALITY( GRIMM FAIRY)

      Europe-Revue littéraire mensuelle
    43. FABRE N; MONTASTRUC JL; RASCOL O
      ALOPECIA - AN ADVERSE EFFECT OF BROMOCRIPTINE

      Clinical neuropharmacology
    44. DELISLE MB; FABRE N; ROCHICCIOLI P; DOERRSCHOTT J; RUMEAU JL; BES A
      CREUTZFELDT-JAKOB-DISEASE IN A CADAVER-DE RIVED HUMAN GROWTH-HORMONE RECIPIENT - A CLINICOPATHOLOGICAL STUDY

      Revue neurologique
    45. MEHLEN P; BRIOLAY J; SMITH L; DIAZLATOUD C; FABRE N; PAULI D; ARRIGO AP
      ANALYSIS OF THE RESISTANCE TO HEAT AND HYDROGEN-PEROXIDE STRESSES IN COS CELLS TRANSIENTLY EXPRESSING WILD-TYPE OR DELETION MUTANTS OF THE DROSOPHILA 27-KDA HEAT-SHOCK PROTEIN

      European journal of biochemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/10/20 alle ore 05:26:07